Zhu et al. reported a case of Gorlin syndrome in a patient with biopsy-proven metastatic BCC to the lung that was refractory to two different SMO inhibitors despite responses in his cutaneous lesions [26]. This evidence concerns the gene SMO and skin basal cell carcinoma.